News
U.S. Trade Representative Jamieson Greer said the Trump Administration excluded pharmaceuticals and semiconductors from reciprocal tariffs ...
Barchart on MSN12d
Stocks Sharply Higher on Hopes for US Trade DealsStock indexes today are sharply higher, recovering some of the enormous losses over the past three sessions that sent the S&P 500 falling nearly 15% from last Wednesday's close. Hopes of a tariff ...
Hosted on MSN19d
Should You Hold QUALCOMM Incorporated (QCOM)?Madison Sustainable Equity Fund stated the following regarding QUALCOMM Incorporated (NASDAQ:QCOM) in its Q3 2024 investor letter: "Alphabet Inc., Eli Lilly and Company, QUALCOMM Incorporated ...
QCOM has been growing its payouts for 21 consecutive ... The company has paid its dividends consistently since 2010. Eli Lilly and Company (NYSE:LLY) is an Indiana-based multinational ...
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results